Lantheus Reports Second Quarter 2024 Financial Results
July 31, 2024 07:00 ET
|
Lantheus Holdings, Inc.
Second Quarter 2024 Worldwide revenue of $394.1 million, an increase of 22.5% from second quarter 2023Completed three strategic transactions to expand innovative pipelineGAAP fully diluted...
Atea Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call on August 7, 2024
July 31, 2024 07:00 ET
|
Atea Pharmaceuticals, Inc.
BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral...
Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update
July 31, 2024 07:00 ET
|
Amarin Corporation plc
-- Cash Position of $307 Million Provides Stable and Strong Capital Foundation –-- Total Net Revenue of $68 Million ($124 Million Year-To-Date) Reflecting Continuing Efforts to Maximize...
Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program
July 31, 2024 07:00 ET
|
Entero Therapeutics, Inc.
BOCA RATON, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors
July 31, 2024 07:00 ET
|
Mural Oncology, Inc.
WALTHAM, Mass and DUBLIN, July 31, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine...
Lantronix Announces CEO and CFO Featured at Canaccord Genuity’s 44th Annual Growth Conference on Aug. 14, 2024
July 31, 2024 07:00 ET
|
Lantronix, Inc.
IRVINE, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions, today announced its participation in the 44th Annual...
Option Care Health Announces Financial Results for The Second Quarter Ended June 30, 2024
July 31, 2024 07:00 ET
|
Option Care Health, Inc.
BANNOCKBURN, Ill., July 31, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate...
Editas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate Update
July 31, 2024 07:00 ET
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that it will host a conference call and webcast...
The Lovesac Company Announces a Five-Year Extension of Its Credit Facility and Inaugural Share Repurchase Program
July 31, 2024 07:00 ET
|
The Lovesac Company
Expands Revolving Credit Facility with 5-Year Extended Maturity Board of Directors Authorizes $40 Million Share Repurchase Program STAMFORD, Conn., July 31, 2024 (GLOBE NEWSWIRE) -- The Lovesac...
Plug to Announce 2024 Second Quarter Results
July 31, 2024 07:00 ET
|
Plug Power, Inc.
SLINGERLANDS, N.Y., July 31, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, will announce its 2024...